Work-induced changes in skeletal muscle IGF-1 and myostatin gene expression in uremia (Q46259720)

20 December 2017

title

Work-induced changes in skeletal muscle IGF-1 and myostatin gene expression in uremia (English)

1 reference

20 December 2017

author name string

Sun DF

series ordinal

1

1 reference

20 December 2017

Chen Y

series ordinal

2

1 reference

20 December 2017

Rabkin R

series ordinal

3

1 reference

20 December 2017

language of work or name

English

0 references

publication date

28 June 2006

1 reference

20 December 2017

published in

Kidney International

1 reference

20 December 2017

volume

70

1 reference

20 December 2017

issue

3

1 reference

20 December 2017

page(s)

453-459

1 reference

20 December 2017

Death risk in hemodialysis patients: the predictive value of commonly measured variables and an evaluation of death rate differences between facilities

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001532

7 January 2021

Revisiting mortality predictability of serum albumin in the dialysis population: time dependency, longitudinal changes and population-attributable fraction

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001532

7 January 2021

Inflammation: cause of vascular disease and malnutrition in dialysis patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001532

7 January 2021

Molecular mechanisms activating muscle protein degradation in chronic kidney disease and other catabolic conditions

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001532

7 January 2021

Skeletal muscle mRNA for IGF-IEa, IGF-II, and IGF-I receptor is decreased in sedentary chronic hemodialysis patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001532

7 January 2021

Impairment of IGF-I gene splicing and MGF expression associated with muscle wasting

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001532

7 January 2021

Skeletal muscle hypertrophy and atrophy signaling pathways

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001532

7 January 2021

Insulin-like growth factor I: the yin and yang of muscle atrophy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001532

7 January 2021

Impaired actions of insulin-like growth factor 1 on protein Synthesis and degradation in skeletal muscle of rats with chronic renal failure. Evidence for a postreceptor defect

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001532

7 January 2021

Impaired metabolic response to recombinant insulin-like growth factor-1 in dialysis patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001532

7 January 2021

Growth hormone/insulin-like growth factor system in children with chronic renal failure

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001532

7 January 2021

Chronic renal disease: a growing problem

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001532

7 January 2021

Impaired JAK-STAT signal transduction contributes to growth hormone resistance in chronic uremia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001532

7 January 2021

Chronic uremia attenuates growth hormone-induced signal transduction in skeletal muscle.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001532

7 January 2021

Molecular physiology, pathology, and regulation of the growth hormone/insulin-like growth factor-I system

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001532

7 January 2021

Effect of training and growth hormone suppression on insulin-like growth factor I mRNA in young rats

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001532

7 January 2021

Impaired exercise capacity and exercise training in maintenance hemodialysis patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001532

7 January 2021

Resistance training to reduce the malnutrition-inflammation complex syndrome of chronic kidney disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001532

7 January 2021

Cardiac resistance to growth hormone in uremia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001532

7 January 2021

In vivo regulation of growth hormone-stimulated gene transcription by STAT5b

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001532

7 January 2021

Long-term treatment of growth retarded children with chronic renal insufficiency, with recombinant human growth hormone

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001532

7 January 2021

Growth hormone induces anabolism in malnourished maintenance haemodialysis patients.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001532

7 January 2021

The growth factor myostatin, a key regulator in skeletal muscle growth and homeostasis.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001532

7 January 2021

Insulin-like growth factor-1 mediates stretch-induced upregulation of myostatin expression in neonatal rat cardiomyocytes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001532

7 January 2021

Myostatin mutation associated with gross muscle hypertrophy in a child

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001532

7 January 2021

Powerful genes--myostatin regulation of human muscle mass

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001532

7 January 2021

Content and localization of myostatin in mouse skeletal muscles during aging, mechanical unloading and reloading.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001532

7 January 2021

Short-term endurance training results in a muscle-specific decrease of myostatin mRNA content in the rat

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001532

7 January 2021

Myostatin gene expression is reduced in humans with heavy-resistance strength training: a brief communication

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001532

7 January 2021

Effects of heavy resistance training on myostatin mRNA and protein expression

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001532

7 January 2021

Voluntary exercise during chronic renal failure in rats

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001532

7 January 2021

Insulin-like growth factor action and skeletal muscle growth, an in vivo perspective

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001532

7 January 2021

Insulin-like growth factor isoforms in skeletal muscle aging, regeneration, and disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001532

7 January 2021

Control of the size of the human muscle mass

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001532

7 January 2021

Normal growth and development in the absence of hepatic insulin-like growth factor I

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001532

7 January 2021

Mechanical signal transduction in skeletal muscle growth and adaptation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001532

7 January 2021

Myostatin: a therapeutic target for skeletal muscle wasting

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001532

7 January 2021

Myostatin, the cardiac chalone of insulin-like growth factor-1

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001532

7 January 2021

Transcriptional effects of chronic Akt activation in the heart.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001532

7 January 2021

Identifiers

DOI

10.1038/SJ.KI.5001532

1 reference

20 December 2017

1 reference

20 December 2017